Faslodex (fulvestrant)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
WARNINGS AND PRECAUTIONS
Injection Site Reaction (addition)
Injection site related events including sciatica,...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts